Tesla Motors (TSLA) rose 2.02% after announcing a $1.6 billion notes offering to grow the business and build its own battery factory, or Gigafactory. Ben Kallow, an analyst at R.W. Baird, says the factory will become the cheapest lithium battery factor out there, and Tesla will own the majority of it. Kallow said the stock still has room to grow.
Grasso said he'd be locking up Tesla profits here around $260 a share. He'd be a buyer at that range once he sees a little bit of support in the stock.
Does it matter that Credit Suisse (CS) has helped U.S. clients hide billions from the IRS, as recent reports show? Finerman pointed to all of the recent JPMorgan Chase (JPM) settlements as evidence that investors really don't care. Nathan disagreed, calling JPMorgan and Bank of America (BAC) dead money right now.
Adami said financials haven't participated in the recent rally. Goldman Sachs (GS) put in its high on the first day of January and has not traded well since.
Ed Morse, global head of commodities at Citi (C), said that recent explosions during rail oil deliveries could impact crude oil prices down the line, but supply is not threatened for now.
LinkedIn (LNKD) popped 1.41% but Nathan thinks momentum seems broken.
First Solar (FSLR) dropped 9.12% and Grasso said that if you believe Tesla is going to sell off, First Solar sells in lockstep so be careful.
Anheuser-Busch Inbev (BUD) jumped 1.6% to close at $103.75 on a big fourth quarter and shouldn't be as volatile as it is, Adami said. If it fails to level above $107 a share, the rally will not continue and it will drop to $94.
Finerman looked at North Atlantic Drilling (NADL), which rose 2% to close at $9.13 a share. With oil prices where they are, ultra-deepwater drillers like NADL and Pacific Drilling (PACD) are way too cheap.
Replying to a question sent via Twitter, Grasso said that there is some support in Coca Cola (KO) but he'd keep it on a short leash with a $37 stop.
For their final trades, Nathan is buying General Motors (GM) and Grasso is buying VeriFone (PAY). Finerman is selling SPDR S&P Biotech (XBI) calls and Adami is buying Chicago Bridge & Iron (CBI).
-- Written by Chris Sahl in Boston.